According to PharmaTimes.com, the two CROs will pursue “extensive strategic partnership” in clinical trial management, data management and statistical analysis. The alliance will broaden the scope of MacroStat’s operations and “add professionalism to Tigermed’s biostatistics services”, the latter said. With the new alliance, will more work be outsourced to China? We'd like to hear your thoughts.
Search This Blog
Blog Archive
-
▼
2009
(141)
-
▼
March
(16)
- Tips and Trends on Global Clinical Trials Outsourcing
- Expert Opinions on the Current State of the CRO ma...
- March Partnerships with CROs LinkedIn Roundup
- Premier Acquires Pivotal Research Centers
- More suicidal monitoring needed in clinical trials?
- i3 Launches New Software to Manage Clinical Trials...
- Staffing services now offered by PharmaNet
- Contract work for clinical trials on the upswing
- A New Low in Drug Research: 21 Fabricated Studies
- CROs in disguise
- Omnicore's CRO sees 2008 profit
- Tigermed, MacroStat forge Chinese CRO alliance
- Tough Economy Slows Down CRO Growth for now
- What's your opinion?
- Win Through a Social Contract: Use Teamwork to Cre...
- Revisiting Ethics of Global Outsourcing
-
▼
March
(16)
No comments:
Post a Comment